Tags : Promotion

Pharma

AstraZeneca Signs an Exclusive Promotion Agreement with Luye Pharma for

Shots: AstraZeneca to get exclusive promotion rights in China including Taiwan, Hong Kong, Singapore, Malaysia for Luye’s Xuezhikang capsules. Luye Pharma will retain its IPR, commercialization rights, asset rights & registration permit rights The focus of the agreement is to promote Xuezhikang in cardiovascular disorders and strengthening Luye’s footprints in cardiology, with its further expansion […]Read More